🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label expanded access protocol for the treatment of up to a...
Status
No Longer Available
Location
Children's Hospital Colorado
Start Date
TBD
Trial ID
NCT02473497
Treatments Being Tested
Tthe primary objective of this study is to compare blinded Independent Radi...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-04-24
Trial ID
NCT03428217
Treatments Being Tested
Drg-drug Interaction (DDI) study to assess the effect of INC280 on the phar...
Status
Completed
Location
Emory University School of Medicine/Winship Cancer Institute SC-2
Start Date
2015-12-10
Trial ID
NCT02520752
the study aim to assess the effect of INC280 on the pharmacokinetics of dig...
Status
Completed
Location
Emory University School of Medicine/Winship Cancer Institute Phase 1 Working Group
Start Date
2015-12-08
Trial ID
NCT02626234
Treatments Being Tested
This study is a phase II, single-arm, open label study under an umbrella tr...
Status
Unknown
Location
Asan Medical Center
Start Date
2018-10-30
Trial ID
NCT03693339
Treatments Being Tested
To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC...
Status
Recruiting
Location
Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute
Start Date
2017-09-27
Trial ID
NCT03175224
Treatments Being Tested
Study to evaluate the efficacy and safety of capmatinib as a single-agent t...
Status
Completed
Location
Pacific Shores Medical Group SC
Start Date
2015-06-11
Trial ID
NCT02414139
Treatments Being Tested
This is an open-label, multicenter, Phase Ib trial designed to evaluate the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07649655
Treatments Being Tested
The purpose of this study is to assess the feasibility of subcutaneous (SC)...
Status
Active Not Recruiting
Location
Cedars Sinai Medical Center
Start Date
2020-11-10
Trial ID
NCT04606381
This is a phase I, multi-center, open-label, single oral dose, parallel gro...
Status
Completed
Location
University of Miami Miller School of Medicine Clinical Resea Oncology
Start Date
2015-06-12
Trial ID
NCT02474537
Treatments Being Tested